Our drug screening device is currently in development.
Sign up to our newsletter for regular updates.
Paul Yates joins Intelligent Fingerprinting as Business Development Manager
30 June 2011 - Intelligent Fingerprinting Ltd, a UK-based company that has developed a unique technology for the simultaneous detection of personal identity and contact with illicit substances from fingerprints is pleased to announce the appointment of Dr Paul Yates as Business Development Manager.
Dr Yates joins Intelligent Fingerprinting following a long career in the Forensic Science Service as a Customer Key Account Manager where he was primarily responsible for implementing successful sales and marketing strategies across different market sectors, management of new sales opportunities and leading bids for national police tenders. During his post, Dr Yates not only successfully negotiated a supra-regional Service Level Agreement, securing business worth in excess of £72m over six years but also developed and sold added-value crime reduction services to ten customers worth more than £10.8m. Dr Yates also led the successful response for company accreditation to the National Forensic Procurement Framework and led the Huntingdon Sales Team.
Prior to joining the Forensic Science Service, Dr Yates worked as a research scientist for both the European Space Agency, Noordwijk, the Netherlands and the Planetary Sciences Unit at the Open University in the UK. He has a BSc in Geochemistry and a PhD in Stable Isotope Cosmochemistry.
Commenting on Dr Yates’ appointment, Terry Swainbank, Investment Director of Synergis Technologies said ‘I am delighted that Paul has joined Intelligent Fingerprinting. Paul brings with him a wealth of experience in successful negotiation, closing deals, procurement of high value contracts and business development across a wide range of market sectors. It is my belief that he will play an important role in driving the Company forward’.
Dr Yates stated ‘I am pleased to be joining Intelligent Fingerprinting at such a crucial and exciting stage in the Company’s development and I hope that my skills in identifying value opportunities and implementing successful sales and marketing strategies will contribute significantly to the team as it enters the next commercial phase’.
Jerry Walker, CEO of Intelligent Fingerprinting added ‘As a key account manager for the Forensics Science Service, Paul has successfully demonstrated his skills in marketing, sales negotiation and business development. His strong commercial background together with his extensive knowledge of the law enforcement and forensics distribution markets will make him a valuable addition to the Intelligent Fingerprinting team’.
Intelligent Fingerprinting, a spin-out from the University of East Anglia has developed methods to determine whether an individual is using drugs from the sweat deposited in a fingerprint. The fingerprint itself provides positive identification of the individual and sweat analysis shows the presence or otherwise of drugs in the body. As the technology detects the metabolites and not the drug itself, it is, therefore, impossible for an individual to avoid detection.
- Ends -